Friday, March 1, 2024 |

UMB, Terran Biosciences forge exclusive licensing deal

March 9, 2022

Terran Biosciences Inc. has entered into an agreement with the University of Maryland, Baltimore for a worldwide exclusive license to develop and commercialize a portfolio of UMB’s patents and data to support a novel approach to the treatment of neurological and psychiatric illnesses with psychedelic therapeutics. Terms of the deal were not disclosed.

Article Source: The Daily Record

The Morning Rundown

We’re staying up to the minute on the issues shaping the future. Join us on the newsletter of choice for Maryland politicos and business leaders. It’s always free to join and never a hassle to leave. See you on the inside.